SiNtx Technologies Inc.
Last updated September 27, 2026
Organization details
- Legal name
- SiNtx Technologies Inc.
- Former names
- Amedica Corp
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Salt Lake City
- Headquarters state / province
- Utah
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SINT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001269026
Board of directors
-
Christopher Michael Lyons · DirectorSince 2026
-
Eric K. Olson · Director · Chairman, President and CEOSince 2024
-
Gregg R. Honigblum · Director · Chief Investment OfficerSince 2024
-
Jay M. Moyes · DirectorSince 2025
-
Mark Lewis Anderson · DirectorSince 2025
Chief executives
Eric K. Olson
· President and CEO
Dates unknown
Director election results
Annual meeting of September 4, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.6%
Board connections
1 of this board's directors also sit on 2 other boards.
- via Jay M. Moyes
- via Jay M. Moyes
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $377,928
- 22 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 13, 2026 | Elmore Robert Ryan Officer (President) | Grant or award | +4,910 | $2.89 | $14,190 |
| Mar 2, 2026 | Christopher Michael Lyons Director | Open-market purchase | +7,534 | $2.90 | $21,849 |
| Feb 25, 2026 | Christopher Michael Lyons Director | Open-market purchase | +758 | $2.96 | $2,244 |
| Feb 23, 2026 | Jay M. Moyes Director | Open-market purchase | +1,000 | $2.91 | $2,910 |
| Feb 18, 2026 | Mark Lewis Anderson Director | Open-market purchase | +3,000 | $3.02 | $9,060 |
| Dec 8, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +3,200 | $4.28 | $13,696 |
| Dec 8, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $4.24 | $21,200 |
| Dec 5, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $3.95 | $19,750 |
| Dec 5, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $3.94 | $19,700 |
| Dec 5, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $4.00 | $20,000 |
| Dec 5, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $4.07 | $20,350 |
| Dec 5, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $4.02 | $20,100 |
| Dec 5, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $3.94 | $19,700 |
| Dec 5, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $3.91 | $19,550 |
| Dec 5, 2025 | Gregg R. Honigblum Director, Officer (Chief Investment Officer) | Open-market purchase | +5,000 | $3.91 | $19,550 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.